230 related articles for article (PubMed ID: 23945089)
21. Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients.
Buiten MS; de Bie MK; Bouma-de Krijger A; van Dam B; Dekker FW; Jukema JW; Rabelink TJ; Rotmans JI
BMC Nephrol; 2014 Dec; 15():197. PubMed ID: 25495997
[TBL] [Abstract][Full Text] [Related]
22. Cardio-ankle vascular index is linked to deranged metabolic status, especially high HbA1c and monocyte-chemoattractant-1 protein, in predialysis chronic kidney disease.
Mert M; Dursun B; Yağcı AB; Çetin Kardeşler A; Şenol H; Demir S
Int Urol Nephrol; 2020 Jan; 52(1):137-145. PubMed ID: 31773386
[TBL] [Abstract][Full Text] [Related]
23. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
24. Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children.
Kunert SK; Hartmann H; Haffner D; Leifheit-Nestler M
J Bone Miner Metab; 2017 Mar; 35(2):215-226. PubMed ID: 27017221
[TBL] [Abstract][Full Text] [Related]
25. Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy.
Farías-Basulto A; Martínez-Ramírez HR; Gómez-García EF; Cueto-Manzano AM; Cortés-Sanabria L; Hernández-Ramos LE; Ramírez-López G; Mendoza-Carrera F
Arch Med Res; 2018 Oct; 49(7):451-455. PubMed ID: 30718148
[TBL] [Abstract][Full Text] [Related]
26. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment.
Martín-Vírgala J; Fernández-Villabrille S; Martín-Carro B; Tamargo-Gómez I; Navarro-González JF; Mora-Fernández C; Calleros L; Astudillo-Cortés E; Avello-Llano N; Mariño G; Dusso AS; Alonso-Montes C; Panizo S; Cannata-Andía JB; Naves-Díaz M; Carrillo-López N
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986200
[TBL] [Abstract][Full Text] [Related]
27. Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease.
Biscetti F; Nardella E; Bonadia N; Angelini F; Pitocco D; Santoliquido A; Filipponi M; Landolfi R; Flex A
Cardiovasc Diabetol; 2019 Jun; 18(1):74. PubMed ID: 31167666
[TBL] [Abstract][Full Text] [Related]
28. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
[TBL] [Abstract][Full Text] [Related]
29. Circulating α-Klotho Levels in Hemodialysis Patients and Their Relationship to Atherosclerosis.
Yu L; Kang L; Ren XZ; Diao ZL; Liu WH
Kidney Blood Press Res; 2018; 43(4):1174-1182. PubMed ID: 30064142
[TBL] [Abstract][Full Text] [Related]
30. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease-Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows.
Martín-Vírgala J; Martín-Carro B; Fernández-Villabrille S; Ruiz-Torres MP; Gómez-Alonso C; Rodríguez-García M; Fernández-Martín JL; Alonso-Montes C; Panizo S; Cannata-Andía JB; Naves-Díaz M; Carrillo-López N
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339121
[TBL] [Abstract][Full Text] [Related]
31. Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy.
Kang WL; Xu GS
Sci Rep; 2016 Jan; 6():19979. PubMed ID: 26813039
[TBL] [Abstract][Full Text] [Related]
32. Soluble Klotho levels in adult renal transplant recipients are modulated by recombinant human erythropoietin.
Leone F; Lofaro D; Gigliotti P; Perri A; Vizza D; Toteda G; Lupinacci S; Armentano F; Papalia T; Bonofiglio R
J Nephrol; 2014 Oct; 27(5):577-85. PubMed ID: 24760622
[TBL] [Abstract][Full Text] [Related]
33. Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease.
Zhong X; Jagarlapudi S; Weng Y; Ly M; Rouse JC; McClure K; Ishino T; Zhang Y; Sousa E; Cohen J; Tzvetkova B; Cote K; Scarcelli JJ; Johnson K; Palandra J; Apgar JR; Yaddanapudi S; Gonzalez-Villalobos RA; Opsahl AC; Lam K; Yao Q; Duan W; Sievers A; Zhou J; Ferguson D; D'Antona A; Zollner R; Zhu HL; Kriz R; Lin L; Clerin V
J Biol Chem; 2020 Mar; 295(10):3115-3133. PubMed ID: 32005658
[TBL] [Abstract][Full Text] [Related]
34. Lower soluble Klotho and higher fibroblast growth factor 23 serum levels are associated with episodes of atrial fibrillation.
Mizia-Stec K; Wieczorek J; Polak M; Wybraniec MT; Woźniak-Skowerska I; Hoffmann A; Nowak S; Wikarek M; Wnuk-Wojnar A; Chudek J; Więcek A
Cytokine; 2018 Nov; 111():106-111. PubMed ID: 30138898
[TBL] [Abstract][Full Text] [Related]
35. Serum α-Klotho and fibroblast growth factor 23 levels are not associated with non-proliferative diabetic retinopathy in type 1 diabetes mellitus.
Oner C; Dogan B; Tuzun S; Ekinci A; Feyizoglu G; Basok BI
Sci Rep; 2024 Feb; 14(1):4054. PubMed ID: 38374169
[TBL] [Abstract][Full Text] [Related]
36. Use of Glycated Hemoglobin (A1c) as a Biomarker for Vascular Risk in Type 2 Diabetes: Its Relationship with Matrix Metalloproteinases-2, -9 and the Metabolism of Collagen IV and Elastin.
Kostov K; Blazhev A
Medicina (Kaunas); 2020 May; 56(5):. PubMed ID: 32403389
[No Abstract] [Full Text] [Related]
37. Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes.
Schneider F; Saulnier PJ; Gand E; Desvergnes M; Lefort N; Thorin E; Thorin-Trescases N; Mohammedi K; Ragot S; Ricco JB; Hadjadj S
Cardiovasc Diabetol; 2018 Jun; 17(1):81. PubMed ID: 29879997
[TBL] [Abstract][Full Text] [Related]
38. Reduced Levels of the Antiaging Hormone Klotho are Associated With Increased Aortic Stiffness in Diabetic Kidney Disease.
Fountoulakis N; Psefteli PM; Maltese G; Gnudi L; Siow RC; Karalliedde J
Kidney Int Rep; 2023 Jul; 8(7):1380-1388. PubMed ID: 37441489
[TBL] [Abstract][Full Text] [Related]
39. Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease.
Seiler S; Wen M; Roth HJ; Fehrenz M; Flügge F; Herath E; Weihrauch A; Fliser D; Heine GH
Kidney Int; 2013 Jan; 83(1):121-8. PubMed ID: 22895520
[TBL] [Abstract][Full Text] [Related]
40. Low levels of circulating anti-ageing hormone Klotho predict the onset and progression of diabetic retinopathy.
Corcillo A; Fountoulakis N; Sohal A; Farrow F; Ayis S; Karalliedde J
Diab Vasc Dis Res; 2020; 17(6):1479164120970901. PubMed ID: 33225726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
